Table 2.
Demographic data, baseline characteristics and laser parameters of the study cohort
| N. of eyes/patients | 34/34 |
|---|---|
| Age (years) | Mean ± SD: 64.7 ± 9.5 |
| Eyes (right/left): N (%) | 19 (55.9%)/15 (44.1%) |
| Gender (male/female): N (%) | 20 (58.8%)/14 (41.2%) |
| Preoperative IOP (mmHg) | Mean ± SD: 21.0 ± 2.69 |
| BCDVA (logmar) | Mean ± SD: 0.1 ± 0.17 |
| C/D Ratio | Mean ± SD: 0.6 ± 0.18 |
| MD (dB) | Mean ± SD: − 3.8 ± 3.59 |
| PSD (dB) | Mean ± SD: 4.4 ± 3.34 |
| Corneal pachymetry (µm) | Mean ± SD: 555 ± 34 |
| Preoperative glaucoma medications | Mean ± SD: 2.2 ± 1.4 |
| Medications: N (%) | PGA: 25 (73.5%) |
| β-Bl: 19 (55.9%) | |
| α-Ag: 13 (38.2%) | |
| CAI: 17 (50%) | |
| Pilocarpin: 3 (8.8%) | |
| Gonioscopy: N (%) | |
| Shaffer 3 (20–35°) | 22 (64.7%) |
| Shaffer 4 (35–45°) | 12 (35.3%) |
| Pigmentation: N (%) | |
| None | 1 (2.9%) |
| I–just visible | 5 (14.7%) |
| II–mild | 16 (47.1%) |
| III–marked | 12 (35.3%) |
| IV–intense | 0 |
| Pseudophacic: N (%) | 6 (17.6%) |
| N. of laser spots | Mean ± SD: 100.7 ± 16 |
| Average laser energy (µJ) | Mean ± SD: 32.7 ± 13.0 |
| Area of treatment (°) | Mean ± SD: 357.4 ± 15.4 |
N—number, IOP—intraocular pressure, BCDVA—best-corrected distance visual acuity, C/D—ratio cup to disk ratio, MD—mean deviation, PSD—pattern standard deviation, PGA—prostaglandin analogs, β-Bl—beta-blockers, α-Ag—alpha-agonists, CAI—carbonic anhydrase inhibitors, SD—standard deviation